Kidney Function Test Market
Kidney Function Test Market Analysis By Test Type (Clearance Tests, Urine Tests, Blood Tests, Dilution & Concentration Tests), By Product Type (Dipsticks, Reagents, Disposables), By End User (Hospitals, Research Laboratories & Institutes, Diagnostic Centers) & By Region – Global Market Report 2023 to 2033
Analysis of Kidney Function Test Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Kidney Function Test Market Outlook (2023 to 2033)
The global kidney function test market was valued at US$ 955 million in 2022. Projections for the assessment period (2023 to 2033) indicate that worldwide sales revenue from kidney disease diagnostics is forecasted to rise at a CAGR of 5% and reach a market value of US$ 1.64 billion by 2033, as per this detailed study by Fact.MR.
The rising cases of chronic kidney diseases, technological advancements taking place in rapid diagnostic tests, and increasing demand for various highly precise kidney function tests are projected to contribute to market growth. Moreover, research initiatives to develop new products are predicted to scale up opportunities for industry players.
- SphingoTec, in January 2022, launched the IB10 sphingotest penKid. It is a point-of-care test that enables real-time evaluation of the functions of the kidney with a normal blood test.
Key Market Growth Drivers
- Surging awareness related to the availability of multiple diagnostic methods for multiple kidney-related disorders is projected to push demand for kidney function assessment kits.
- Increasing number of individuals suffering from hypertension and diabetes is leading to rising prevalence of kidney disorders, which is contributing to the sales of test machines.
Kidney function tests are rapid blood and urine tests that aid in the identification and assessment of any issues that are related to kidneys. Players are investing heavily in more advanced testing kits.
- Elypta AB, in January 2020, raised a seed of US$ 7 million for the development of the first urine test against kidney cancer.
Comparatively high cost of kidney function tests along with lower adoption rate across underdeveloped and developing countries is forecasted to obstruct market growth opportunities.
- Demand for kidney disease diagnostics in China is projected to increase at a CAGR of 4.7% and reach a market value of US$ 245 million by 2033-end.
- Worldwide demand for dipsticks is forecasted to rise at 5.6% CAGR and reach a valuation of US$ 692 million by 2033.
|Kidney Function Test Market Size (2022A)||US$ 955 Million|
|Estimated Market Value (2023E)||US$ 1 Billion|
|Forecasted Market Value (2033F)||US$ 1.64 Billion|
|Global Market Growth Rate (2023 to 2033)||5% CAGR|
|United States Market Value (2022)||US$ 285 Million|
|Dipsticks Segment Value (2033)||US$ 692 Million|
|Japan Market Growth Rate (2023 to 2033)||4.8% CAGR|
|Germany Market Growth Rate (2023 to 2033)||4% CAGR|
|Key Companies Profiled||
Don't Need a Global Report?
save 40%! on Country & Region specific reports
What is Driving the Growth of the Kidney Function Test Market?
“Rising Prevalence of Kidney Diseases Worldwide”
The growing prevalence of kidney diseases is forecasted to serve as one of the key growth-driving factors in the market. This is characterized by the rising number of people being diagnosed with several kidney-related conditions, including diabetic nephropathy, hypertension-related kidney problems, and chronic kidney disease (CKD).
- In 2018, the BMC Nephrology Journal estimated that people suffering from kidney diseases exceeded 850 million with around 843 million accounting for CKD. In addition, a two-fold increase in mortalities from CKD over the past three decades accounted for a noteworthy disease burden.
Kidney function tests are adopted as pivotal tools for the diagnosis of kidney diseases at the initial level, thus guiding treatment decisions and improving patient outcomes.
“Escalating Healthcare Expenditure Improving Access to Better Diagnostic Tests”
The growing healthcare expenditure, especially in emerging economies, is projected to play a significant role in facilitating access to more advanced diagnostic tests, including kidney function tests. The phenomenon is anticipated to reflect the noticeable impact of growing healthcare funding as well as investment in healthcare infrastructure.
Adoption of advanced medical equipment, modernization of healthcare facilities, and training of healthcare professionals are some significant improvements in healthcare infrastructure. These investments are crucial for effective diagnostic services and help in the proliferation of the market.
Why is Adoption of Kidney Function Test Machines Limited?
“Higher Prices of Kidney-related Tests Limiting Adoption of Kits”
High prices of kidney function tests are projected to negatively impact market growth opportunities, especially in underdeveloped and emerging countries. Financial restraints in these areas are predicted to limit the adoption of kidney function test panels in the coming decade.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
What is the Contribution of Start-ups to Market Growth?
“Development of Technologically Advanced Kidney Function Tests”
Start-ups trying to enter the global market can take advantage of rapidly evolving smartphone technology. The development of advanced tests that can operate with smartphone help players generate lead.
- Bloom Diagnostics, in August 2022, developed a smart system to detect various medical disorders. This is a new addition to the company’s portfolio.
Focus on R&D initiatives is also projected to help new entrants excel in the market. Fast-track innovations in the prevention, diagnosis, and treatment of renal diseases are predicted to improve the lives of people suffering from kidney diseases.
North America is forecasted to become a dominant region in the global market because of its well-established healthcare infrastructure, favorable reimbursement policies, and supportive government initiatives. Demand for kidney function tests in Asia Pacific is projected to increase at a CAGR of 8.4% because of the growing prevalence of different types of kidney diseases that positively impact the demand for kidney function biomarkers for rapid diagnosis and treatment.
- In 2020, the Australian Institute of Health and Welfare reported approximately 17,700 fatalities attributed to chronic kidney disease (CKD), accounting for around 11% of deaths in Australia that year.
Why are Suppliers of Kidney Function Test Kits Investing in the United States?
“Growing Emphasis on Innovation and Advanced Detection Capabilities”
The United States market reached US$ 285 million in 2022. Some prominent manufacturers in the country are concentrating on developing innovative and more advanced products.
- Abbott HealthTab, Inc., in November 2021, entered into an agreement for i-STAT Alinity with Abbott. This product is a handheld blood chemistry analyzer and its distribution can help patients gain information related to kidney functions.
Which Countries in Asia Pacific are Attracting Key Market Players?
“Heavy Investments in CKD-related Awareness Campaigns in China and Japan”
Demand for renal function tests in China is projected to increase at a CAGR of 4.7% and reach a value of US$ 245 million by 2033-end. Furthermore, the Japanese market is predicted to expand at a 4.8% CAGR through 2033. Several private as well as government organizations in Japan and China are investing to introduce some awareness programs related to chronic kidney diseases that are predicted to promote the demand for kidney function testing.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
As per the newly published research report by Fact.MR, a market research and competitive intelligence provider, worldwide demand for urine tests is projected to accelerate at 7.7% CAGR through 2033 owing to their growing use to assess renal function to detect dysfunction and renal illness. Based on product type, worldwide sales of dipsticks are projected to advance at a CAGR of 5.6% and reach US$ 692 million by 2033-end.
What Makes Hospitals Key End Users of Kidney Function Testing Equipment?
“Rising Hospitalization Fueling Demand for Effective Diagnostic Interpretation”
Hospitals contributed around 40% to the global revenue share in 2022 due to rising incidences of hospitalization that are generating requirements for diagnostic interpretation for treatment. Various diagnostic centers collaborate with hospitals, which is also adding to revenue streams.
The constant development of healthcare infrastructure is predicted to enhance the current hospital facilities and thus expand their offerings and services. Therefore, contributing to the thriving demand for products, including kidney function tests, etc.
Which Type of Kidney Function Test is Gaining Prominence Globally?
“Optimum Precision of Clearance Tests Bolstering Global Demand”
Clearance tests held 28% share of the global market revenue in 2022 and are predicted to continue their dominance during the assessment period. These are the gold standards adopted for monitoring and measurement of glomerular filtration rate. Creatinine and inulin tests are included in these tests and are important additions to conventional diagnostic tests for precise results.
Minimal variation in performance is ensured through these tests due to their optimum precision and sensitivity. Easy availability and pocket-friendly prices of clearance tests boost their adoption.
Suppliers of kidney function test panels are adopting some strategies to attain their goals, including new developments, ensuring quality control of products, management of supply chain systems, etc. Key players are implementing several strategies, including geographical expansion, product launches, collaborations, and partnerships to expand their global presence.
- Bloom Diagnostics launched The Bloom Kidney Test in August 2022. This test is designed specifically for adult patients for cystatin C’s quantitative measurement in whole blood. This product is predicted to improve product offerings and assist the company in extending its global reach.
- Nova Biomedical, in March 2022, launched a tool to offer advanced renal care through the detection of kidney disease and kidney function screening in POC settings outside hospitals.
Prominent kidney function testing device companies include Abbott Laboratories, 77 Elektronika Kft, Acon Laboratories, Inc., Beckman Coulter, Inc., Arkray, Inc., F. Hoffmann-La Roche AG, Opti Medical Systems, Inc., Nova Biomedical Corporation, Randox Laboratories Ltd., Sysmex Corporation, Siemens Healthineers, and Urit Medical.
Segmentation of Kidney Function Test Market Research
By Test Type :
- Clearance Tests
- Urine Tests
- Blood Tests
- Dilution & Concentration Tests
By Product Type :
By End User :
- Research Laboratories & Institutes
- Diagnostic Centers
By Region :
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
- FAQs -
The global kidney function test market reached US$ 955 million in 2022.
Sales of kidney function test kits in the United States reached US$ 285 million in 2022.
Worldwide sales of kidney function test kits stand at US$ 1 billion in 2023.
Worldwide demand for kidney function test kits is projected to increase at a CAGR of 5% through 2033.
The market for kidney function testing is set to reach US$ 1.64 billion by the end of 2033.
The Japanese market is forecasted to expand at a CAGR of 4.8% from 2023 to 2033.
GFR is opted as an optimal way for the measurement of kidney function that is in conjunction with albuminuria and helps to determine the CKD extent in an individual.